Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Am Heart J. 2017 Jun 9;191:21–29. doi: 10.1016/j.ahj.2017.06.002

Figure 2.

Figure 2

Kaplan-Meier curves depicting differences in survival among patients randomized to ICD versus no ICD among (A) NYHA class II and (B) NYHA class III patients. The differences in the risk of death by treatment group were assessed using unadjusted Cox proportional hazards models.